Research Article

You have full text access to this OnlineOpen article

Danazol therapy for aplastic anemia refractory to immunosuppressive therapy

  1. Tatsuya Chuhjo1,
  2. Hirohito Yamazaki2,
  3. Mitsuhiro Omine3,
  4. Shinji Nakao2,*

Article first published online: 27 DEC 2007

DOI: 10.1002/ajh.21118

Issue

American Journal of Hematology

American Journal of Hematology

Volume 83, Issue 5, pages 387–389, May 2008

Additional Information

How to Cite

Chuhjo, T., Yamazaki, H., Omine, M. and Nakao, S. (2008), Danazol therapy for aplastic anemia refractory to immunosuppressive therapy. Am. J. Hematol., 83: 387–389. doi: 10.1002/ajh.21118

Author Information

  1. 1

    Department of Internal Medicine, NTT Kanazawa Hospital, Kanazawa, Ishikawa, Japan

  2. 2

    Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan

  3. 3

    Division of Hematology, Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan

*Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8641, Japan

Publication History

  1. Issue published online: 16 APR 2008
  2. Article first published online: 27 DEC 2007
  3. Manuscript Accepted: 31 OCT 2007
  4. Manuscript Revised: 29 OCT 2007
  5. Manuscript Received: 4 MAR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (67K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Patrick Ziegler, Hubert Schrezenmeier, Jamil Akkad, Ute Brassat, Lucia Vankann, Jens Panse, Stefan Wilop, Stefan Balabanov, Klaus Schwarz, Uwe M. Martens, Tim H. Brümmendorf, Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation, Annals of Hematology, 2012,

    CrossRef

  2. 2
    Kathrin Scheckenbach, Mary Morgan, Judith Filger-Brillinger, Matthias Sandmann, Bruce Strimling, Wolfram Scheurlen, Detlev Schindler, Ulrich Göbel, Helmut Hanenberg, Treatment of the bone marrow failure in Fanconi anemia patients with danazol, Blood Cells, Molecules, and Diseases, 2012, 48, 2, 128

    CrossRef

  3. 3
    José Carlos Jaime-Pérez, Perla R. Colunga-Pedraza, Cynthia D. Gómez-Ramírez, César H. Gutiérrez-Aguirre, Olga G. Cantú-Rodríguez, Luz C. Tarín-Arzaga, David Gómez-Almaguer, Danazol as first-line therapy for aplastic anemia, Annals of Hematology, 2011, 90, 5, 523

    CrossRef

  4. 4
    Wolfgang Füreder, Peter Valent, Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches, Leukemia & Lymphoma, 2011, 52, 8, 1435

    CrossRef

Get PDF (67K)